TLSA Tiziana Life Sciences Ltd
Tiziana Life Sciences Ltd (TLSA) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: August 5, 2026 , by Elrifi Ivor .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Elrifi Ivor | Chief Executive Officer | Buy | 237,616 | $1.00 | $237.6K | 4,793,684 | |
| Elrifi Ivor | Chief Executive Officer | Buy | 83,807 | $0.97 | $81.3K | 4,556,068 | |
| Elrifi Ivor | Chief Executive Officer | Buy | 667,000 | $1.00 | $667.0K | 4,472,261 | |
| CERRONE GABRIELE M | Director | Buy | 42,357 | $0.99 | $41.9K | 44,814,587 | |
| CERRONE GABRIELE M | Director | Buy | 15,000 | $1.11 | $16.7K | 44,772,230 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.